Anthony Bates Foundation
Medical Education
Home
Events
Pre-Register
Screening Forms
Medical Education
Educ. & Awareness
Fundraising
Give a Gift of Life
Cookbooks
Merchandise
Past Events
Our Story
Pictures
Newsletters
News Stories
Current Press Release
MPHS Heart Screening
Video
Help Wanted
Contact Us
Our People
Testimonies
Stories about Anthony
Links

Education & Awareness is the main purpose of the Anthony Bates Foundation. 
There is a wide bridge between wisdom gained from parents that have lost
a child to Sudden Cardiac Arrest and the knowledge of medical professionals.
Our goal in this section is to share our wisdom to bridge the gap!

Sharon Bates has had eight years of immersion as it relates to the cardiac

condition known as Hypertrophic Cardiomyopathy, HCM.  Recently while

in Italy, Sharon heard Dr. Arbustini, Florence, Italy state, “Medical school

& specialty school students are lucky to have 1 hour of

cardiomyopathy training and barely have a genetic subject.” This

made an impression on her to share what she learns to doctors and medical

professionals everywhere.

 

These notes were taken during the Florence International Course on Advances

in Cardiomyopathies – May 22/24, 2008.  There is a wealth of information

and contacts to professionals in the field that are making a difference in this

“not so rare” condition.

 

Share this web-sites and these notes with your colleagues!

Part 1 Contains 10 pages that include:
* Intro
* Table of Contents
* Guest Faculty Contact Information
* May 22 Pre-Opening Sessions
 
Click on the link below to open the PDF file
     \/                   \/                 \/

Advances in Cardiomyopathy Part 1

Part 2 Contains 10 pages that includes:
* Official Opening
  Session 1
* General principles: nomenclature, classification, mechanisms
* The contemporary classifications of cardiomyopathies
* Genetic basis of cardiomyopathies:  an overview
* Molecular mechanisms of dysfunction and failure
* Contribution of pathology to the understanding of cardiomyopathies
* Role of endomyocardial biopsy in 2008
  Session 2
* HCM diagnosis and clinical assessment
* Diagnostic criteria, differential diagnosis and clinical spectrum
* Cardiac involvement in Anderson Fabry disease
* Pathophysiology of symptoms and disease progression
* Echo verses MRI for clinical management
* Assessment of microvascular dysfunction and significance of ischemia
* Future applications of cardiac MRI imaging
  Session 3
* HCM translational research: insights from basic science and clinical genetics
 
Click on the link below to open the PDF file
     \/                   \/                 \/

Advances in Cardiomyopathy Part 2

Part 3 Contains 10 pages that includes:
* Lessons from mouse models
* Biophysical consequences of sarcomere gene mutations
* Old genes, new genes and correlations with phenotype
* Disease mechanisms in inherited DCM
   Session 4
* HCM clinical management
* An overview of contemporary treatment options
* State-of-the-art management of atrial fibrillation and ventricular arrhythmias
* Prevention of systemic embolism:  old and new drugs
Round Table: How to relieve LVOT obstruction

Lessons learned from four decades of surgical myectomy

Lessons learned from a decade of alcohol septal ablation

 
Click on the link below to open the PDF file
     \/                   \/                 \/

Advances in Cardiomyopathy Part 3

Part 4 Contains 10 pages that include:
* Restorative tailored surgical approach
* Panel discussion

    Session 5

* LV dysfunction, dilated Cardiomyopathy and ARVC
* Genetic screening in the clinical setting: state-of-the-art
* Update on ARVC: morphological spectrum and outcome

* Clinical management of ARVC

* Restrictive cardiomyopathies and children

* Cardiomyopathies in children including LV non compaction

* Differential diagnosis and management of cardiac amyloidoses

* Tropical neglected cardiomyopathies

    Session 7

* Round Table:  How to implement education and translational research in cardiomyopathies

* The Italian perspective

    Session 8

* Sudden death prevention:  ICD patient selection and risk/benefit ratio

* In HCM

* In DCM and ARVC

 

Click on the link below to open the PDF file
     \/                   \/                 \/

Advances in Cardiomyopathy Part 4

Part 5 Containes 10 pages that contain:
* In athletes and in the young
* Prevention and management of ICD-related complications
* Discussion
Young Investigator Awards 

    Session 9

New advances in CRT, LVAD, heart transpland and regenerative medicine
New directions for cardiomyopathies:  what’s next
Patient selection and expected benefits of cardiac resynchronization therapy
Gene therapy and stem cells:  dream or reality
Lecture: New advances in reverse remodeling and regenerative medicine
Conclusion and final remarks 

Poster Session: P1 through P14 

 

Click on the link below to open the PDF file
     \/                   \/                 \/

Advances in Cardiomyopathy Part 5

Part 6 Contains 4 pages that include:

* Poster Session:  P14 through P26

* Poster Session:  P27 through P38

* Poster Session:  P39 through P51

* Poster Session:  P48 through P60

 

Click on the link below to open the PDF file

     \/                   \/                 \/

Advances in Cardiomyopathy Part 6